Back to Search
Start Over
Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy
- Publication Year :
- 2017
- Subjects :
- Oncology
Neuroblastoma RAS viral oncogene homolog
medicine.medical_specialty
Massive parallel sequencing
Bevacizumab
business.industry
Colorectal cancer
First line
Hematology
medicine.disease
medicine.disease_cause
Internal medicine
Triplet chemotherapy
Genotype
Cancer research
Medicine
KRAS
business
medicine.drug
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....58ea231e88316ec51eda275f981cf61d